跳至主要内容
临床试验/NL-OMON37225
NL-OMON37225已完成不适用

Possibilities of measuring Infliximab in patients with Ulcerative Colitis or Crohn's Colitis - IFX in feces

Academisch Medisch Centrum0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -patients (>18 years) with Ulcerative Colitis or Crohn's Colitis who start on Infliximab therapy

排除标准

  • History of previous Infliximab use

研究者

相似试验

进行中(未招募)
不适用
Measurement of levels of infliximab and anti-infliximab antibodies inrheumatic patients
EUCTR2013-004969-14-FIHeidi Mäkinen150
进行中(未招募)
1 期
BackToBasic: The effect of Infliximab in patients with chronic low back pain and vertebral oedema on MRI scan.A randomized, double blind, placebo-controlled, multicenter trialon-specific chronic low back pain of more than 6 months duration. We will only investigate those who have vertebral end-plate chanages(Modic changes) on MRI.MedDRA version: 20.0Level: LLTClassification code 10008837Term: Chronic back painSystem Organ Class: 100000004859
EUCTR2017-004861-29-NOFOU, Nevroklinikken, Oslo University Hospital -Ullevål126
已完成
不适用
Study of the pharmacokinetics of Infliximab (IFX) in moderate to severe Ulcerative ColitisInflammatory Bowel Disease10017969Ulcerative Colitis
NL-OMON37516Academisch Medisch Centrum20
进行中(未招募)
1 期
EFFICACI : EFFicacy of intravenous Infliximab versus vedolizumab after failure of subCutaneous Anti-TNF in patients with UlCerative colitis : A double blinded Randomized Clinical Trial.lcerative colitisMedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856
EUCTR2018-002673-21-FRCentre Hospitalier Universitaire de Rennes150
已完成
不适用
Efficacy of Infliximab as a second Bio in patients with refractory rheumatoid arthritisRheumatoid arthritis
JPRN-UMIN000020799Hokkaido University Hospital, Medicine II30